HTG Molecular Diagnostics, Inc.
3430 E. Global Loop
Tucson, AZ 85706
April 15, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
| Re: | HTG Molecular Diagnostics, Inc. (the “Company”) |
Registration Statement on Form S-3 (File No. 333-264210)
Acceleration Request
Requested Date: Tuesday, April 19, 2022
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Tuesday, April 19, 2022, or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Steven M. Przesmicki of Cooley LLP at (858) 550-6070 or Asa M. Henin of Cooley LLP at (858) 550-6104.
Sincerely,
| HTG MOLECULAR DIAGNOSTICS, INC. |
/s/ Shaun D. McMeans |
| Shaun D. McMeans |
| SVP and Chief Financial Officer |
